You are here: Industry Insights > Skin cancer

News List

MSD's Keytruda bags approval for new skin cancer indication pharmatimes
June 29, 2020
MSD's Keytruda (pembrolizumab) has been cleared for use in the US as monotherapy for the treatment of patients with recurrent or metastatic cutaneous squamous cell carcinoma (cSCC) not curable by surgery or radiation.
Scientists double understanding of genetic risk of melanoma expresspharma
April 29, 2020
Melanoma is a sometimes-deadly skin cancer, with an estimated 350,000 cases worldwide in 2015, resulting in nearly 60,000 deaths.
EMA confirms skin cancer risk with LEO's Picato pharmatimes
April 20, 2020
The European Medicines Agency's safety committee (PRAC) has confirmed that LEO's Laboratories' Picato (ingenol mebutate), used to treat the skin condition actinic keratosis, may increase the risk of skin cancer.
3Derm Announces Two FDA Breakthrough Device Designations for Autonomous Skin Cancer AI americanpharmaceuticalreview
January 13, 2020
3Derm Systems has been granted two FDA Breakthrough Device designations for 3DermSpot, an algorithm that uses artificial intelligence (AI) and highly standardized skin images to autonomously detect melanoma, squamous cell carcinoma, and basal cell carcino
Weight-Loss Surgery Might Also Lower Skin Cancer Risk drugs
January 07, 2020
Weight-loss surgery does more than shed pounds: new research suggests it might also lower your risk for skin cancer. "This provides further evidence for a connection between obesity and malignant skin cancer ...
Brachytherapy Treats Skin Cancer in Elderly Patients drugs
December 26, 2019
Excellent local control and cosmetic outcomes are observed in elderly patients receiving high dose-rate brachytherapy (HDRBT) for early-stage nonmelanoma skin cancer of the head and neck region ...
Regeneron's Libtayo is chugging along in skin cancer. Next stop? First-line lung fiercepharma
February 24, 2019
Regeneron CEO Len Schleifer has called its brand-new cancer drug Libtayo “the engine that could.” And Wednesday, those wondering, “could what?” got a glimpse at what the PD-1 latecomer has done so far.
Too Much Time in the Sun? Skin Patch Might Tell drugs
December 06, 2018
A new mint-sized, battery-free patch that alerts wearers to potentially harmful sunlight exposure in real time might become a powerful weapon in preventing skin cancer....
NHS funds BMS’ Opdivo to prevent skin cancer returning pharmaphorum
December 03, 2018
NICE has recommended interim NHS funding for Bristol-Myers Squibb’s cancer immunotherapy, Opdivo to prevent early stage skin cancer from recurring, overturning a decision earlier this year to reject the drug in this indication.
NHS green light for Novartis skin cancer combo pharmatimes
October 19, 2018
The NHS now has three months to ensure that Novartis’ combination therapy dabrafenib/trametinib is routinely available to eligible skin cancer patients, after cost regulators published guidance backing funds for the treatment.

Previous page 1 2 3 Next page